European Pharmaceutical Review

MARCH 28, 2024

How does the qualification package support more meaningful endpoints and rare disease research as a result? Each of those studies represents a group of families that have given up their time, money, literal blood and flesh in pursuit of definitive answers they deserve for their efforts.

FDA 52

FDA Packaging Communication Insurance 52

Pharmaceutical Technology

FEBRUARY 23, 2023

Fraction absorbed is directly related to the solubility, dissolution, and permeability of a compound and is the amount of drug that enters the intestinal enterocyte in our gastrointestinal tract (FDA definition), whereas bioavailability (F) is the amount of drug in the systemic circulation able to have a therapeutic effect.

Compounding 98

Compounding Dosage Packaging Communication 98

The FDA Law Blog

NOVEMBER 2, 2023

The guidance describes elements that would be required of VCS bodies for recognition of standards they adopt: openness (with meaningful opportunities to participate), balance (broad range of stakeholders), due process, an appeals process, and consensus.

FDA 59

FDA Packaging Documentation Labelling 59

DiversifyRx

JULY 11, 2024

While the product identifier on the package will still be used during investigations, you may not be able to connect the physical product to the transaction information since the product identifier may not be contained within the transaction information. For additional information on identifying full-time employees, see [link].

Independent Pharmacies 52

Independent Pharmacies FDA Documentation CPhT 52

ISPE

MARCH 29, 2023

Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment. Currently, it takes time and/or communications (e.g.,

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment. Currently, it takes time and/or communications (e.g.,

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 15, 2023

4 The biopharmaceutical industry is taking steps to increase its environmental sustainability, 5 which begins with identifying and testing alternatives to existing procurement, materials, logistics, equipment, services, manufacturing processes, packaging, and facility design 6 (see Table 1). 7 An integrative (vs. 7 An integrative (vs.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

pharmaphorum

APRIL 11, 2022

The answer to this question comes back to our definition of value. Data will always be central to everything we do, as it has the power to communicate the potential of a new treatment to change a person’s life. And it all fuels the debate: are medicines a cost or an investment?

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

ISPE

AUGUST 29, 2022

For changes requiring approval before implementation, once the necessary information has been submitted across regions, each health authority must review the data package and documentation based on local requirements. IDMP Definition of Identification of Medicinal Products.” Common Technical Document [CTD] sections). 26 Tschorn, U.

Documentation 52

Documentation FDA Communication Packaging 52

The Digital Apothecary

AUGUST 15, 2017

Personally, I haven't seen this much attention in awhile about pharmacy since PillPack made strip-packaging of medications mainstream three-years ago, and am quite eager to see if this is really going to change the current paradigm of pharmacy services.

Mail-Order Pharmacies 52

Mail-Order Pharmacies Health and Personal Care Stores Insurance Medication Dispensing 52

Pharmaceutical Technology

JUNE 12, 2025

They have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations.” RFK Jr stated in an X post that: “All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense. Give your business an edge with our leading industry insights.

Vaccines 52

Vaccines Hospitals Communication Immunization 52

ISPE

SEPTEMBER 11, 2023

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). Nature Communications 12, no. Biotechnology Progress 36, no. 3 (2020):e2970.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

NOVEMBER 2, 2022

Pfizer was able to build close to two years of supply of products for the vaccine; it had to quickly scale up for producing billions of doses in a very short period of time, so Pfizer looked to ramp up drug substance, drug product, and packaging in many sites around the world in record time. Celebrate success and milestones. Andres Angelani.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Hospitals 98

PharmTech

JUNE 12, 2025

The warnings encompassed various forms of lack of compliance in the agency’s view, including product mislabeling, false or misleading claims on packaging, and shortfalls in current good manufacturing practice (CGMP) standards found during laboratory inspections.

FDA 59

FDA Dosage Compounding Labelling 59